“…Furthermore, some virulence factors are more prevalent in specific urinary tract infectious diseases, thus offering insights into future vaccine development (Jantunen et al 2000;Ruiz et al 2002;Tseng et al 2002). We sought to further elucidate the roles of E. coli virulence factors in the development of urosepsis and two other severe renal parenchymal infectious diseases, APN and ALN, in (Cheng et al, 2010b). Twenty-five virulence factors were analyzed, including genes associated with fimbrial and nonfimbrial adhesins (papAH,papC,papEF,papG I,papG II,papG III,sfaS,focG,afa,bmaE,gafD,nfaE,fimH),toxins (hlyA,cnf1,cdtB), siderophores (fyuA, iutA), capsule synthesis (kpsMT II, kpsMT III), invasion of brain endothelium (ibeA), serumresistance (traT), markers for virulence-associated E. coli serogroup O4 (rfc) and colcin V plasmids (cvaC), and the coding region of PAI from the uropathogenic strain CFT073 (PAI) (Johnson and Stell 2000;Jantunen et al 2000;Tseng et al 2002;Johnson and Kuskowski et al 2005;Cheng et al 2007).…”